BRCA2 and cancer: PARP is an enzyme involved in DNA transcription and repair, and its inhibition is useful to treat tumors with mutations in BRCA1 (breast cancer gene 1) and BRCA2 (breast cancer gene 2) and other genes involved in the repair of homologous recombination deficits.